Rogco, LP Merck & Co., Inc. Transaction History

Rogco, LP

$245 Billion
Q4 2024

A detailed history of Rogco, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rogco, LP holds 8,104 shares of MRK stock, worth $725,308. This represents 0.33% of its overall portfolio holdings.

Number of Shares

8,104

Previous 8,068 0.45%

Holding current value

$725,308

Previous $916 Million 12.01%

% of portfolio

0.33%

Previous 0.36%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$96.31 - $114.76 $3,467 - $4,131	36 Added 0.45%	8,104 $806 Million
Q3 2024 Oct 22, 2024	SELL	$111.15 - $128.97 $74,470 - $86,409	-670 Reduced 7.67%	8,068 $916 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $8,170 - $8,775	-66 Reduced 0.75%	8,738 $1.08 Billion
Q1 2024 May 08, 2024	BUY	$113.24 - $131.95 $74,964 - $87,350	662 Added 8.13%	8,804 $1.16 Billion
Q4 2023 Feb 06, 2024	BUY	$100.18 - $109.02 $373,671 - $406,644	3,730 Added 84.54%	8,142 $888 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $454,215 - $504,423	4,412 New	4,412 $454 Million

Others Institutions Holding MRK

# of Institutions

3,952

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rogco, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rogco, LP with notifications on news.

Account